Add to ORKGSkin and corneal wounds in diabetics are a major healthcare burden. MicroRNAs are small, non-coding RNAs that post-transcriptionally regulate the expression of protein-coding genes. Studies have identified microRNAs involved in all phases of wound healing. The dysregulation of microRNAs can contribute to impaired or delayed skin and corneal wound healing in diabetics. Here, we present a comprehensive review of the literature involving microRNAs in diabetic skin and corneal wound healing as well as those serving as potential biomarkers for diabetic wound healing
Diabetes mellitus (DM) is a complex metabolic disorder. Long-term hyperglycemia may induce diabetic ...
Wound healing is a complex process involving inflammation, cellular proliferation, and matrix remode...
Clinical skin manifestations are common in diabetes, often being the first sign of the metabolic dis...
Overweight and obesity are major problems in today's society, driving the prevalence of diabetes and...
Overweight and obesity are major problems in today’s society, driving the prevalence of diabetes and...
<div><p>MicroRNAs are powerful gene expression regulators, but their corneal repertoire and potentia...
MicroRNAs are powerful gene expression regulators, but their corneal repertoire and potential change...
MicroRNAs are powerful gene expression regulators, but their corneal repertoire and potential change...
The growing pipelines of RNA-based therapies herald new opportunities to deliver better patient outc...
Diabetes mellitus is a worldwide pandemic, affecting 29 million Americans, resulting in substantial ...
Diabetic chronic cutaneous ulcers (DCU) is one of the serious complications of diabetes mellitus, wh...
MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators of gene expression, and have ...
Chronic wounds are a major burden to overall healthcare cost and patient morbidity. Chronic wounds a...
MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators of gene expression, and have ...
Chronic non-healing foot ulcers are a major complication of diabetes, occurring in 25% of patients w...
Diabetes mellitus (DM) is a complex metabolic disorder. Long-term hyperglycemia may induce diabetic ...
Wound healing is a complex process involving inflammation, cellular proliferation, and matrix remode...
Clinical skin manifestations are common in diabetes, often being the first sign of the metabolic dis...
Overweight and obesity are major problems in today's society, driving the prevalence of diabetes and...
Overweight and obesity are major problems in today’s society, driving the prevalence of diabetes and...
<div><p>MicroRNAs are powerful gene expression regulators, but their corneal repertoire and potentia...
MicroRNAs are powerful gene expression regulators, but their corneal repertoire and potential change...
MicroRNAs are powerful gene expression regulators, but their corneal repertoire and potential change...
The growing pipelines of RNA-based therapies herald new opportunities to deliver better patient outc...
Diabetes mellitus is a worldwide pandemic, affecting 29 million Americans, resulting in substantial ...
Diabetic chronic cutaneous ulcers (DCU) is one of the serious complications of diabetes mellitus, wh...
MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators of gene expression, and have ...
Chronic wounds are a major burden to overall healthcare cost and patient morbidity. Chronic wounds a...
MicroRNAs (miRNAs) have emerged as key post-transcriptional regulators of gene expression, and have ...
Chronic non-healing foot ulcers are a major complication of diabetes, occurring in 25% of patients w...
Diabetes mellitus (DM) is a complex metabolic disorder. Long-term hyperglycemia may induce diabetic ...
Wound healing is a complex process involving inflammation, cellular proliferation, and matrix remode...
Clinical skin manifestations are common in diabetes, often being the first sign of the metabolic dis...